Platform
Company
Coagulation
Review status
Currently under review
Pending specialist review and validation.
This test measures how well your von Willebrand factor works to help platelets stick together and form an initial plug to stop bleeding. In the laboratory, a substance called ristocetin is used to trigger a platelet response that depends on your von Willebrand factor, so the result reflects the functional activity of this protein. Von Willebrand factor also carries and stabilizes factor VIII in your blood, which is why this assay is often linked to factor VIII in bleeding evaluations.
The test is commonly ordered as part of a bleeding workup along with von Willebrand factor antigen and factor VIII activity. It can also be used to monitor how you respond to treatments that release or replace von Willebrand factor, especially around procedures where bleeding control is important.
Results help your care team confirm or rule out von Willebrand disease and distinguish a functional problem from a low amount of the protein. This distinction guides treatment choices, such as whether medicines that release stored von Willebrand factor, replacement concentrates, or other strategies are most appropriate.
Your clinician may order this test if you have easy bruising, frequent nosebleeds, heavy menstrual bleeding, bleeding after dental work or surgery, or a family history of bleeding. It is also useful for planning and monitoring therapy around procedures, making sure your levels and function are adequate to reduce bleeding risk.
A lower activity result suggests that your von Willebrand factor is not working as it should, which can contribute to easy bleeding. When the activity is interpreted together with von Willebrand factor antigen and factor VIII activity, your clinician can tell whether the issue is mainly about function, amount, or both, and tailor care accordingly.
Some conditions can temporarily raise von Willebrand factor and make activity appear closer to normal even if an underlying problem exists. Stress, infection, inflammation, pregnancy, and estrogen therapy can do this. If results do not match your bleeding history, your clinician may repeat testing when you are well, use additional specialized assays, or adjust timing around treatments. If activity is higher than expected, it usually does not cause symptoms, and your team will interpret it in the context of your overall health.
Reference intervals vary by laboratory, analyzer, methodology, population, and units. The ranges shown here are for education only. Always interpret your results against the reference interval printed on your own lab report.
Underfilled blue-top citrate tubes, very high hematocrit, hemolysis, delayed processing, or warm storage can falsely lower measured activity. Proper fill, prompt centrifugation, and temperature control help ensure accurate results.
Fever, infection, inflammation, recent strenuous exercise, pain, or emotional stress can transiently raise von Willebrand factor activity. If possible, testing when you are well and rested provides a more reliable baseline.
Pregnancy and estrogen-containing medications tend to increase von Willebrand factor and its activity. Your clinician may repeat testing after delivery or after stopping hormones to assess your baseline.
People with blood group O often have lower baseline von Willebrand factor compared with other groups. This physiologic variation can influence results without indicating a specific disorder.
Desmopressin, von Willebrand factor or factor VIII concentrates, cryoprecipitate, and intravenous immunoglobulin can raise activity. Antiplatelet drugs do not directly change this assay but can increase bleeding. Tell your clinician about recent therapies.
Von Willebrand factor activity tends to rise with age and can be affected by thyroid, liver, or inflammatory diseases. Interpreting results in the context of your overall health is important.
References